Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised controlled trial of trans-anal versus trans-vaginal repair for symptomatic anterior rectocoele
ISRCTN ISRCTN58192664
ClinicalTrials.gov identifier
Public title A randomised controlled trial of trans-anal versus trans-vaginal repair for symptomatic anterior rectocoele
Scientific title
Acronym N/A
Serial number at source N0050166862
Study hypothesis A rectocoele is a common problem caused by weakness in the tissues of the pelvis, which leads to problems with defecation. A number of surgical approaches to repair of a rectocoele are available. Currently in our institution a patient will have rectocoele repair either through the anus or through the vagina. No consensus of opinion exists as to which is the superior approach. The aim of this study is to randomise the patients to one or the other operation to establish which approach is superior.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Urological and Genital Diseases: Rectocoele
Participants - inclusion criteria Research participants will be recruited from the outpatient clinic once they have been identified by preoperative investigation to be suitable for surgical repair of their rectocoele. Inclusion criteria:
1. The presence of excessive straining, incomplete evacuation
2. The requirement for perineal/vaginal digital pressure during defecation
3. Vaginal bulging and constipation, due to a rectocoele as proven on defaecography, in the presence of a normal large bowel.
These are standard indications for rectocoele repair.

62 patients will be recruited in to the study from the department of Colorectal Surgery and Gynaecology, 31 patients will be in each arm.
Participants - exclusion criteria Patients with a slow transit colon or sphincter defects as these patients have been shown not to benefit from rectocoele repair.
Anticipated start date 02/06/2005
Anticipated end date 01/02/2006
Status of trial Completed
Patient information material
Target number of participants 62
Interventions Patients will be selected from the clinics for suitability for surgical repair of their rectocoele following appropriate investigations. All patients will be assessed in a structure manner. A specific questionnaire will be filled in by the patient preoperatively. This questionnaire includes SF-36v2 global quality of life assessment tool, the Cleveland continence scoring toll and specific questions on defecation habits, and dyspareunia.

The presence of a symptomatic rectocele in the absence of other pathology renders the patient suitable for inclusion into the trial and after providing adequate information and fully informed consent they will be randomised to transanal or transvaginal repair. This would happen preoperatively to allow the patient to be counselled and consented about the exact procedure they will undergo.
Primary outcome measure(s) Functional outcome and quality of life changes by the surgery.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Bradford Teaching Hospitals NHS Foundation Trust (UK) Own Account
Trial website
Publications
Contact name Mr  Richard  Baker
  Address Bradford Royal Infirmary
Duckworth Lane
  City/town Bradford
  Zip/Postcode BD9 6RJ
  Country United Kingdom
  Tel +44 (0)1274 452200
  Email richard.p.baker@tinyonline.co.uk
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 28/06/2010
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central